Researchers at Stanford have developed a new catalog of compact transcription effector domains and fused them onto DNA binding domains to engineer synthetic transcription factors.
Stanford researchers at Prof. Safavi-Naeini's laboratory have developed a high quality, scalable processor architecture using small, phononic crystal resonators for read-out and long-lived storage in superconducting circuit quantum computing.
Stanford researchers have identified a biomarker on cartilage precursor cells that can predict which cells will develop into inflammation-resistant and functionally appropriate tissue for autologous transplants to treat osteoarthritis.
The CheXbert labeler accurately detects the presence or absence of 14 common medical conditions in radiology reports, converting unstructured radiology text into a structured format.
Derek F. Amanatullah and his research group developed an instrumented retractor that was designed to record the applied force, duration, and angle of retraction during a piriformis-sparing posterior approach to the hip.
The Murmann lab has developed a method for an extraction information from acoustic signals that utilizes low power consumption. N-path filters are used to decompose the original acoustic signals' waveform before downconverting to lower their Nyquist-rate bandwidth.
Stanford researchers have developed a library of polymeric hydrogel formulations to prevent and/or reduce biofouling on implanted sensors and medical devices.
Researchers in the Dionne group at Stanford have designed a nanoscale laser capable of self-isolated Raman Lasing, where lasing and isolation occurs within the same pumping mechanism.
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an efficacious therapy for patients with life-threatening leukemias, but its use has been hindered by the limited availability of donors with matching HLA. Graft manipulation by removing ??
The inventors have identified and developed an archaeal light-driven chloride pump (NpHR) from Natronomonas pharaonis for temporally precise optical inhibition of neural activity. NpHR allows either knockout of single action potentials, or sustained blockade of spiking.
Ion channel dysfunctions lead to a wide array of illnesses including epilepsy, cardiac arrhythmia and type II diabetes. However, the number of clinically approved drugs for restoring normal ion channel function is limited.
Researchers from Prof. Karl Deisseroth's laboratory have developed techniques for specifically modulating the activity of excitable cells in vivo. This approach introduces light-responsive proteins to create photo-sensitive cells.